Picks 101

[lrice]

I have purchased HLUN, a company with an MD for CEO, and offices in clinic, with research extending to China.
I believe it is reasonable to expect some success in their clinical trials, now underway.
Could get to over 20 cents as a new holding range with anticipation of news to take HLUN into the dollars.

As of Jan 9,2007 the 2 year chart and 6months chart RSI and DMI are uptrending. Moving up fast recently. RSI just breaking over 50

Still low trading vol and low share price compared to 2 year chart. Potential back over a dollar. Depends on news. Some are accumulating and holding for the expected good string of news stories, ie success with stem cell/fat cell technology.




January 9, 2007 - 9:45 AM EST

HLUN 0.085 0.01
Today 5d 1m 3m 1y 5y 10y

Healtheuniverse Advances Adult Stem Cell Commercial Applications for Wound Healing and Bioengineered Surgical Products
Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products announced today that the Company's patented adult stem technology will be used to advance commercial applications focused on accelerated wound healing with decreased scarring. The Company is expanding its presence in the wound care field and is working on the development of living wound healing products and bioengineered surgical products based on its proprietary adult stem cell technology.

Dr. Vipul Dev MD, Chief Executive Officer of Healtheuniverse Inc. stated, "Wound care is currently estimated to be a $100 Billion market in the U.S. and growing significantly as the Baby Boomer generation ages. While we're excited by the growth in this target market we believe that by continuing to invest in both internal and external research within the wound care area we can also strengthen our product lines in the plastic, reconstructive, and cosmetic surgery market. Most importantly, we believe we'll be able to bring a dramatic improvement in care to patients in our clinics by offering the newest and latest advances in stem cell therapy."

About HEALTHeUNIVERSE Inc.

HEALTHeUNIVERSE Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery.

Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at http://healtheuniverse.com/

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Source: Market Wire (January 9, 2007 - 9:45 AM EST)



===================== another news interest capsule ====
COVINA, CA -- (MARKET WIRE) -- 12/11/06 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products, announced today that intellectual property in development is moving toward a progenitor cell line that is proprietary to the Company. This seminal research will lead to the development of various cell lines that will be utilized to cultivate cells to form functional human tissue or substitutes. These unique cell lines offer an alternative to human embryonic stem cells for medical treatments avoiding the destruction of embryos.

International commercial applications for these progenitor cell lines in development will be utilized for both non-surgical and surgical areas. Non-surgical applications will be focused on skin rejuvenation and minor wound reparative processes. Surgical applications in process are addressing major wound repair and reconstructive areas such as formation of new skin, new bone, and nerve cells.


Dr. Vipul Dev, MD, Chief Executive Officer of Healtheuniverse, stated, "It is unlikely that one source of stem cells can be used to treat all medical problems and diseases, but different clinical problems could be addressed by using adult cells taken from different areas throughout the body, without the same ethical concerns associated with embryonic stem cells."


Full Disclaimer: Do not buy or sell based on my thoughts.
The above is for my spare time entertainment only.
This is not an offer, nor a solicitation to buy or sell.